Literature DB >> 4727918

Activation of the alternate complement pathway by autologous red cell stroma.

T R Poskitt, H P Fortwengler, B J Lunskis.   

Abstract

The present study demonstrates the ability of human autologous RBC stroma to activate the alternate complement pathway (C3-Activator system, properdin system), as evidenced by the generation of C3-Activator (C3A) from C3-Proactivator (C3PA) when RBC ghosts and sonicated ghosts are incubated with autologous serum. Intact RBC's, hemoglobin, and concentrated platelet stroma, on the other hand, are inactive in this regard. We postulate that this in vitro activity of RBC stroma may occur intravascularly when erythrocytes are damaged by immune or nonimmune mechanisms. The ensuing interaction of activated complement components with platelets leading to release of platelet factor three (PF-3) may constitute a mechanism for activation of the coagulation system during acute hemolytic episodes.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4727918      PMCID: PMC2139415          DOI: 10.1084/jem.138.3.715

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Rapid method for separation of blood cells.

Authors:  A Tellez; P Rubinstein
Journal:  Transfusion       Date:  1970 Jul-Aug       Impact factor: 3.157

2.  The role of intravascular haemolysis and the reticulo-endothelial system in the production of a hypercoagulable state.

Authors:  S F Rabiner; L H Friedman
Journal:  Br J Haematol       Date:  1968-02       Impact factor: 6.998

3.  Coagulation and fibrinolytic studies in paroxysmal nocturnal haemoglobinuria.

Authors:  C J Amris; N E Hansen
Journal:  Acta Med Scand       Date:  1968-12

4.  Mechanisms of release of constituents from rabbit platelets by antigen-antibody complexes and complement. I. Lytic and nonlytic reactions.

Authors:  P M Henson
Journal:  J Immunol       Date:  1970-08       Impact factor: 5.422

5.  Platelets and the triggering mechanism of intravascular coagulation.

Authors:  S A Evensen; M Jeremic
Journal:  Br J Haematol       Date:  1970-07       Impact factor: 6.998

6.  Intravascular coagulation due to inter-donor incompatibility.

Authors:  D Abbott; S Hussain
Journal:  Can Med Assoc J       Date:  1970-10-10       Impact factor: 8.262

7.  Intravascular activation of the clotting system with phospholipids. Production of the generalized Shwartzman reaction with platelet factor 3.

Authors:  F Rodríguez-Erdmann
Journal:  Blood       Date:  1965-11       Impact factor: 22.113

8.  Prevention of the localized and generalized Shwartzman reactions by an anticomplementary agent, cobra venom factor.

Authors:  J S Fong; R A Good
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

9.  The role of the platelet in the generalized Shwartzman reaction.

Authors:  W Margaretten; D G McKay
Journal:  J Exp Med       Date:  1969-03-01       Impact factor: 14.307

10.  Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.

Authors:  H Gewurz; H S Shin; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  9 in total

1.  Complement activation in asymptomatic patients with sickle cell anaemia.

Authors:  W A Wilson; E J Thomas; J G Sissons
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

2.  Alternative complement pathway activity in sera from patients with sickle cell disease.

Authors:  S M Koethe; J T Casper; G E Rodey
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

3.  Activation of the alternative pathway of human complement by haemoglobin.

Authors:  W A Wilson; E J Thomas
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

4.  Loss of expression of neutrophil proteinase-3: a factor contributing to thrombotic risk in paroxysmal nocturnal hemoglobinuria.

Authors:  Anna M Jankowska; Hadrian Szpurka; Mark Calabro; Sanjay Mohan; Andrew E Schade; Michael Clemente; Roy L Silverstein; Jaroslaw P Maciejewski
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

5.  Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients.

Authors:  Elaine M Sloand; Loretta Pfannes; Phillip Scheinberg; Kenneth More; Colin O Wu; McDonald Horne; Neal S Young
Journal:  Exp Hematol       Date:  2008-10-26       Impact factor: 3.084

6.  Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentae.

Authors:  F Tedesco; O Radillo; G Candussi; A Nazzaro; T E Mollnes; D Pecorari
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

7.  Defective yeast opsonisation and functional deficiency of complement in sickle cell disease.

Authors:  V F Larcher; R J Wyke; L R Davis; C E Stroud; R Williams
Journal:  Arch Dis Child       Date:  1982-05       Impact factor: 3.791

Review 8.  The central role of extracellular vesicles in the mechanisms of thrombosis in paroxysmal nocturnal haemoglobinuria: a review.

Authors:  Bérangère Devalet; François Mullier; Bernard Chatelain; Jean-Michel Dogné; Christian Chatelain
Journal:  J Extracell Vesicles       Date:  2014-03-24

9.  Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.

Authors:  R D Schreiber; O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.